In the following video, Fool contributor Maxxwell Chatsko recaps the latest earnings results from the pharmaceutical industry for investors. Some Big Pharma companies have traversed the patent cliff in relatively good shape with new therapies waiting in the wings to fill the void in sales. Others, such as AstraZeneca (NYSE:AZN) and Eli Lilly (NYSE:LLY), are just beginning their slide, but their immediate and long-term futures are more difficult to pin down.
Max Macaluso, Ph.D. has no position in any stocks mentioned. Fool contributor Maxx Chatsko has no position in any stocks mentioned. Check out his personal portfolio, his CAPS page, or follow him on Twitter @BlacknGoldFool to keep up with his writing on energy, bioprocessing, and emerging technologies.
The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.